chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dry mouth; mucosal dryness in mouth; This is a spontaneous report from a Contactable pharmacist. A unspecified  age female patient received the first dose of  bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number unknown, Expiration date unknown), via an unspecified route of administration, on 16Jan2021 at single dose for Covid-19 immunization. The patient medical history and concomitant medication were not reported. The patient experienced Dry mouth, mucosal dryness in their mouths. The outcome of event was unknown.  Information on the lot/ batch number has been requested; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021130811 same reporter/ drug ,different event/patient
I started feeling bad on 07/17/2022, I have a cough, congestion, body aches, chills and low grade fever. I could also feel that my lungs were congested. My symptoms was moderate. I did a Telemedicine and my doctor prescribe my Paxlovid for 5 days.
Severe Hypotension, Redness, Warmth and sensitivity all over skin surfaces, lack of responsiveness, low oxygen saturation.
Fluid buildup in lungs. Than pneumonia set in.; Fluid buildup in lungs. Than pneumonia set in.; Weakness; lethargic; This is a spontaneous report from a contactable consumer. A 61-year-old female patient received BNT162B2 (BNT162B2) via an unspecified route of administration, administered in Arm Left on 13Feb2021 (Lot Number: EN6200) as SINGLE DOSE for covid-19 immunization. The patient's medical history was not reported. Concomitant medication included oxycodone hydrochloride, oxycodone terephthalate, paracetamol (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]) taken for an unspecified indication, start and stop date were not reported. The patient experienced fluid buildup in lungs. than pneumonia set in, weakness and lethargic on 15Feb2021. Therapeutic measures were taken as a result of all the events which includes Medicine and breathing treatments. Outcome of the events was recovering.
Patient's throat started to close up.  Epipen was administered, and her breathing returned to normal.
Fever 101 F; Loss of appetite; Loss of sense of Smell; Loss of sense of Taste; Very Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), ANOSMIA (Loss of sense of Smell), AGEUSIA (Loss of sense of Taste), FATIGUE (Very Fatigue) and PYREXIA (Fever 101 F) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Hashimoto's thyroiditis and Peripheral neuropathy.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced DECREASED APPETITE (Loss of appetite), ANOSMIA (Loss of sense of Smell), AGEUSIA (Loss of sense of Taste) and FATIGUE (Very Fatigue). On 10-Feb-2021, the patient experienced PYREXIA (Fever 101 F). On 15-Jan-2021, FATIGUE (Very Fatigue) had resolved. On 11-Feb-2021, PYREXIA (Fever 101 F) had resolved. At the time of the report, DECREASED APPETITE (Loss of appetite), ANOSMIA (Loss of sense of Smell) and AGEUSIA (Loss of sense of Taste) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) negative.
02/20/22 presents to ED for "hematemesis and melena". PMHx of "alcoholic cirrhosis and esophageal varices s/p banding on 6/2021"
fell asleep for about an hour or two; fatigue; soreness at the injection site; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (fell asleep for about an hour or two), FATIGUE (fatigue), VACCINATION SITE PAIN (soreness at the injection site), HEADACHE (headache) and CHILLS (chills) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 012M20A) for COVID-19 vaccination.     The patient's past medical history included Lung cancer (survivor, in remission patient had surgery in 2014, but status will be NED (No evidence detected)) from 2008 to 2014. Concurrent medical conditions included Follicular B-cell non-Hodgkin's lymphoma (stage 2 NHL, survivor, since 2019 chronic remission) since 2016, Immunocompromised since 2016, Visual impairment (visually impaired) since 07-Mar-2020, Food allergy (Red dye), Food allergy (blue dye), Hypertension (Had this for 30-40 years.), Vestibular abnormalities since 2021, Migraine and Allergy NOS (Had a long list of allergies.). Concomitant products included ATENOLOL for Blood pressure management, CLONAZEPAM for Migraine, LIOTHYRONINE SODIUM (LIOTHYRONIN), LEVOTHYROXINE SODIUM (UNITHROID), LOSARTAN POTASSIUM, VITAMIN D [VITAMIN D NOS], VITAMIN B [VITAMIN B NOS], MAGNESIUM CITRATE, CALCIUM CITRATE, BRIMONIDINE TARTRATE, TIMOLOL MALEATE (COMBIGAN), CICLOSPORIN (RESTASIS), LATANOPROST, CARBOMER (REFRESH [CARBOMER]), ERYTHROMYCIN, HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), MELATONIN and POLYETHYLENE GLYCOL [MACROGOL] for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 03-Mar-2021, the patient experienced SOMNOLENCE (fell asleep for about an hour or two), FATIGUE (fatigue), VACCINATION SITE PAIN (soreness at the injection site), HEADACHE (headache) and CHILLS (chills). The patient was treated with ACETAMINOPHEN ongoing since an unknown date at a dose of 500 milligram and Manual therapy (cool/icy compress on the site) for Vaccination site pain. On 04-Mar-2021, SOMNOLENCE (fell asleep for about an hour or two), FATIGUE (fatigue), VACCINATION SITE PAIN (soreness at the injection site), HEADACHE (headache) and CHILLS (chills) had resolved.            Current condition included blood pressure. Patient was currently being treated for vision impairment , however her treatment had been delayed due to the pandemic. Patient reported that she never had a fever after receiving the shots.  Concomitant medication taken by the patient included Acetaminophen.   This case was linked to MOD-2021-027528, MOD-2022-474724 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Feb-2022: Follow up was received and the patient demographics, medical history,vaccine information, concomitant medications  were  updated. Event fever was deleted as patient mentioned thatshe never had a fever after receiving the shots.
NOT BREATHING WELL FOR 2 DAYS; SECOND SHOTS WORN ME OUT DOWN; This spontaneous report received from a patient via social media post and concerned a male patient of unspecified age, unknown race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: Patient was born with bad lungs. The patient previously received covid-19 vaccine ad26. cov2. s (unspecified manufacturer) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination (Dose number in series 1).It was unknown whether the patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1).  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination (Dose number in series 2). The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient was not breathing well for 2 days and second shots worn out down (dose number in series 2).It was reported that the patient did two shots and that was enough. Second shots worn them out down and not breathed well for 2 days. Patient did not wanted to take chance The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from not breathing well for 2 days (reported as "unknown" but reported by patient to have lasted for 2 days), and the outcome of second shots worn me out down was unknown. This report was non-serious. This case, involving the same patient is linked to 20211233378.
Patient had COVID-19, treatment of Covid-19; Patient had COVID-19, treatment of Covid-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Mar2021 as dose 1, single (Batch/Lot number: unknown), in Jun2021 as dose 2, single (Batch/Lot number: unknown) and in Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) and other medications in two weeks included: ZOLOFT; SPIRONOLACTONE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "Patient had COVID-19, treatment of Covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Aug2022) Positive; (18Aug2022) Positive, notes: Tested positive for COVID again with at home test (Rapid). Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient was treated for events from 05Aug2022 to 09Aug2022 with anti-viral product Paxlovid. The patient tested positive for COVID again with at home test (Rapid) on 18Aug2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax & pt exp contact dermatitis & was treated w/antihistamines & lotion;pt recovered;
I have COPD and it flared up after my vaccination. I experienced difficulty breathing very shortness of breath.
Client received MCV4 - and HPV - both to (L) arm - Hept. B Rt. arm - came in today stated no pain, arm - warm to touch, redness to site.
Swelling and pain at injection site.  Swelling has increased over time.  Patient taking acetaminophen and diphenhydramine.
BRUISE  IN LEFT ARM/ ABOVE LEFT EYE; THROAT CONSTRICTION; This spontaneous report received from a patient concerned a 64 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included no alcohol use, non-smoker, penicillin allergy, and allergic to latex, and other pre-existing medical conditions included patient had history of severe allergies. The patient experienced drug allergy when treated with azithromycin, and diphenhydramine hydrochloride. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the subject experienced bruise in left arm/ above left eye. On 02-APR-2021, the subject experienced throat constriction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from throat constriction on 03-APR-2021, and had not recovered from bruise in left arm/ above left eye. This report was non-serious.
administration of expired Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine). On 23-Nov-2021, EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.   No treatment was given to the patient.   The vaccines were stored in freezer, were taken out one to two vials and placed in fridge each day as needed.
Pt was accidentally given the Moderna vaccine for the first dose instead of the Pfizer vaccine which is approved for pt's under 18.
Headache, myalgia, low grade fever, pain at injection site, extreme fatigue.  Managed with Tylenol and rest.
In October 2022, after vacation, I began to feel bad on the plane home.  I tested negative on October 7, 2022.  I had a sore throat and body aches.  At 3:00am I woke up with a 103 fever.  I tested positive for COVID-19.  I went to the clinic.  Day two I had body aches and felt feverish.  I was sick for about 8 days.  My CT scan last month and I have scarring due to the COVID-19.  My brain fog lasted until the end of December and remained short of breath and tired.
Soreness at injection site from 2/19/2021 until 2/21/2021. Swelling and itching at injection site from 2/26/2021 until present 2/27/2021.
temperature excursion was 67F worst case scenario; total time of excursion was 8 days with no reported adverse event; Initial information received on 14-Jan-2022 regarding an unsolicited valid non-serious case  from a other health professional.  This case a 67 years old female patient who involves a temperature excursion was 67f worst case scenario; total time of excursion was 8 days with no reported adverse event while receiving vaccine Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MCR5)/HIB(PRP/T) vaccine (Pentacel).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect suspension for injection Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MCR5)/HIB(PRP/T) (strength, dose, route, expiry date: unknown) lot UJ577AAA in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious "temperature excursion was 67f worst case scenario; total time of excursion was 8 days with no reported adverse event (intercepted product storage error)" (unknown latency) following the administration of Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MCR5)/HIB(PRP/T) vaccine.  It was reported that "temperature excursion for PENTACEL due to it being left on the counter; temperature excursion was 67F worst case scenario; total time of excursion was 8 days; confirms product was not administered post excursion. Medical assistant asks for stability information".   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (temperature excursion was 67F worst case scenario; total time of excursion was 8 days with no reported adverse event).  At time of reporting, the outcome was Unknown for the event temperature excursion was 67f worst case scenario; total time of excursion was 8 days with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Additional information received on 03-Mar-2022 regarding an unsolicited valid non-serious case  from  other health professional.  Case updated to valid case and patient's demographics added.
Elevated creatinine Kinase levels; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD CREATINE PHOSPHOKINASE INCREASED (Elevated creatinine Kinase levels) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD CREATINE PHOSPHOKINASE INCREASED (Elevated creatinine Kinase levels). At the time of the report, BLOOD CREATINE PHOSPHOKINASE INCREASED (Elevated creatinine Kinase levels) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications and treatment information were reported.
MUSCLE ACHES; TIRED; CRAMPS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 08-MAR-2021 to Left Deltoid for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-MAR-2021, the subject experienced muscle aches. On 08-MAR-2021, the subject experienced tired. On 08-MAR-2021, the subject experienced cramps. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from muscle aches, tired, and cramps. This report was non-serious.
Tenderness on the left (Non-dominant) arm; soreness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Tenderness on the left (Non-dominant) arm) and MYALGIA (soreness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021 at 9:03 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (Tenderness on the left (Non-dominant) arm) and MYALGIA (soreness). At the time of the report, INJECTION SITE PAIN (Tenderness on the left (Non-dominant) arm) and MYALGIA (soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information not provided Treatment information not provided.
Rash to lower arms, face and neck. Appear on the 17th. Today is 10-23-08 rash still over my lower arms.
Began experiencing recurring L kidney pain 5/24/21.  Never had kidney pain before.
New Arthritic nodules and deforming on fingers and new arthritic pain to right ankle that has not stopped.      Shingles developed same time on left side of stomach.
4/16/03 after hairs message rec'd, fever 102.5. Using Tylenol since 8a, 12n, 8pm. Vaccines 4/15/03.
We left the store and got a bite to eat at the drive through. After driving about 7 minutes she grabbed her throat and started acting like she was not able to swallow. I asked her was she ok? She stated no in a raspy voice. She shook her head and said she felt like molasses was in her throat. She seemed pale and began to sweat. I am a former EMT-Parmamedic. I remembered there was a store about 2 miles away. I called  and got the Pharmacist on the phone. I ran into the  after driving 92 miles an hour and she converted children's Benadryl for me and stayed on the phone. I gave her 1/2 a bottle. began to be more responsive. I had a medical bag with me with airways and other medical devices I use for work but no Epi Pen. After giving her all the Benadryl she said she felt better but she stayed hoarse for the remainder of the day and was sleepy. I kept an eye on her an Called her physician on Monday morning as this was a Saturday and they called in Epi pens in case this happens again. The first shot she felt like she swallowed a potato chip wrong and started acting the same way then through up but never got this bad. We just thought she ate something and it went down the wrong way. Never giving it a second thought. Then after the second shot it was much worse. Had I not the pharmacist on the phone, Benadryl liquid and a medical bag, I would have called an ambulance. In the county we live in though we do not have enough ambulances and I am afraid she would have went into full anaphylaxis and died. I did what I thought was the best for my only child.
Dose leaked out; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Dose leaked out) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced ACCIDENTAL UNDERDOSE (Dose leaked out). On 23-Apr-2021, ACCIDENTAL UNDERDOSE (Dose leaked out) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
Numbness in left side of face ( left jaw, cheek, and corner of mouth),  started about 20 minutes after vaccine was given, and was completely gone in 2 hours.